Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07379866
NA

Glossopharyngeal and Maxillary Nerve Blocks in Adenotonsillectomy

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

This study aims to compare of bilateral ultrasound-guided glossopharyngeal nerve (UGGNB) and ultrasound-guided maxillary nerve (UGMNB) versus conventional multimodal analgesia for tonsillectomy operations.

Official title: Ultrasound Guided Glossopharyngeal and Maxillary Nerve Blocks for Perioperative Pain Control in Adenotonsillectomy in Pediatrics: A Randomized Controlled Trial.

Key Details

Gender

All

Age Range

5 Years - 13 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2026-01

Completion Date

2026-06

Last Updated

2026-02-02

Healthy Volunteers

Yes

Interventions

PROCEDURE

ultrasound-guided glossopharyngeal nerve block (UGSGNB)

For the procedure, anesthesiologist will turn patient face carefully toward the clinician, and a linear ultrasound probe will be placed in the neck to check the surrounding target structures: the sternocleidomastoid muscle, the common carotid artery, and the internal jugular vein. After the sternocleidomastoid muscle has been identified, a linear ultrasound probe will be placed parallel to sternocleidomastoid muscle fiber direction just caudal to the mandibular ramus. The stylohyoid muscle is easily visualized by tiling the linear ultrasound probe toward the mandibular ramus. In this area, the stylohyoid muscle is positioned under the sternocleidomastoid muscle, and both can be observed under ultrasound guidance. A 25-gauge, 25-mm needle will be inserted deeply under the stylohyoid muscle through the sternocleidomastoid muscle via an out-of-plane approach. An ultrasound-guided nerve block will be performed with 3 mL of 0.25% bupivacaine after the absence of blood backflow is confirmed.

PROCEDURE

ultrasound-guided maxillary nerve (UGMN)

Curvilinear ultrasound probe will be placed in infra-zygomatic area, over maxilla, angled 45° cephalad. This probe position allows visualization of pterygopalatine fossa, limited anteriorly by maxilla and posteriorly by greater wing of sphenoid. A 22- gauge, 5-cm needle will be inserted perpendicularly to the skin following aseptic preparation of the skin at the frontozygomatic angle formed by posterior orbital rim and zygomatic. Once contact was made with the greater wing of sphenoid, needle will be redirected caudally and medially, and advances through the pterygomaxillary fissure into pterygomaxillary fossa. needle will be advanced using an out-of-plane approach, and needle tip can usually be identified during movements. Needle placement will be verified by real-time ultrasound guidance and negative aspiration before administration of 3-4 ml of 0.25 % bupivacaine. The same procedure will be then repeated on the contralateral side.

PROCEDURE

Placebo Block

ultrasound-guided maxillary nerve (UGMN) and ultrasound-guided glossopharyngeal nerve block (UGSGNB) using normal saline as placebo effect

Locations (1)

Cairo University Hospitals

Cairo, Governorate, Egypt